Amiodarone-Induced Delirium
Mr. A was a 54-year-old man with a history of idiopathic cardiomyopathy and congestive heart failure with ventricular tachycardia who was admitted for worsening congestive heart failure and a new onset of atrial fibrillation. He was discharged 4 days later on a new drug regimen that included bumetanide, 4 mg b.i.d., enalapril, 20 mg b.i.d., and amiodarone, 400 mg b.i.d. Four days after his discharge, Mr. A’s wife reported that he was experiencing mental status changes consisting of depression, paranoia, lessened sleep, and rambling speech. After 3 days of persistent altered mental status, she brought him to the emergency department. Mr. A was evaluated and sent home with a lower dose of amiodarone (200 mg b.i.d.). His mental status and ability to sleep initially improved but distinctly worsened 3 days later.Mr. A was subsequently admitted to the psychiatry service with confusion, tangential thinking, labile affect, and a new macular rash on his extremities. Laboratory test results were normal except for a serum sodium level of 127 meq/liter and a BUN of 35 mg/dl. The results of a computerized tomographic scan of the head were normal. Mr. A had no previous psychiatric history. All drugs were discontinued, and he received 2 mg each of haloperidol and lorazepam.On the fourth hospital day, he was alert and oriented with good memory and concentration, and the rash noted on admission had disappeared. However, on this same day, he was transferred to the cardiac critical care unit with worsening congestive heart failure, renal dysfunction, and a serum potassium level of 6.9 meq/liter, a creatinine level of 1.8 mg/dl, and a sodium level of 126 meq/liter.After 5 days in the cardiac critical care unit (his ninth hospital day), Mr. A resumed taking amiodarone, 200 mg/day, for worsening atrial fibrillation. No other medications were added. Mr. A received 3 days of amiodarone treatment, and on the fourth day, he was noted to be increasingly agitated, confused, and paranoid. He was subsequently treated with haloperidol. Four days after discontinuing the amiodarone, Mr. A returned once again to his baseline normal mental status. Laboratory values and cardiac perfusion remained abnormal, but no further mental status changes occurred. On hospital day 22, Mr. A died because of progressive heart failure.
References
Information & Authors
Information
Published In
History
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
PDF/ePub
View PDF/ePubGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).